In this episode, TRC Healthcare editor, Sara Klockars, PharmD, BCPS, discusses a new drug for COPD, ensifentrine (Ohtuvayre). 

This is an excerpt from our September 2024 Pharmacy Essential Updates continuing education webinar series.

The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights: 

• Article: Watch for Ensifentrine (Ohtuvayre) for COPD
• Chart: Inhaled Medications for COPD

Don’t miss out! Subscribe to Pharmacist’s Letter today to stay ahead with trusted insights and tools. 

If you're a student, good news—students can access a free version of Pharmacist’s Letter.

Send us a text

Email us: [email protected].

The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

Learn more about our product offerings at trchealthcare.com.